IL147507A0 - T-cell receptor y and uses thereof - Google Patents

T-cell receptor y and uses thereof

Info

Publication number
IL147507A0
IL147507A0 IL14750700A IL14750700A IL147507A0 IL 147507 A0 IL147507 A0 IL 147507A0 IL 14750700 A IL14750700 A IL 14750700A IL 14750700 A IL14750700 A IL 14750700A IL 147507 A0 IL147507 A0 IL 147507A0
Authority
IL
Israel
Prior art keywords
cell receptor
receptor
cell
Prior art date
Application number
IL14750700A
Other languages
English (en)
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Publication of IL147507A0 publication Critical patent/IL147507A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14750700A 1999-07-13 2000-07-12 T-cell receptor y and uses thereof IL147507A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14356099P 1999-07-13 1999-07-13
US15747199P 1999-10-01 1999-10-01
PCT/US2000/019039 WO2001004309A1 (en) 1999-07-13 2000-07-12 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF

Publications (1)

Publication Number Publication Date
IL147507A0 true IL147507A0 (en) 2002-08-14

Family

ID=26841157

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14750700A IL147507A0 (en) 1999-07-13 2000-07-12 T-cell receptor y and uses thereof

Country Status (15)

Country Link
US (1) US7052703B1 (zh)
EP (1) EP1200585A1 (zh)
JP (1) JP2004512809A (zh)
KR (1) KR20020026530A (zh)
CN (1) CN1378594A (zh)
AU (1) AU781925B2 (zh)
BR (1) BR0012446A (zh)
CA (1) CA2379345A1 (zh)
HK (1) HK1049499A1 (zh)
IL (1) IL147507A0 (zh)
MX (1) MXPA02000560A (zh)
NO (1) NO20020110L (zh)
PL (1) PL354186A1 (zh)
RU (1) RU2002103722A (zh)
WO (1) WO2001004309A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512809A (ja) * 1999-07-13 2004-04-30 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，　リプリゼンテッド　バイ　ザ　セクレタリー　オブ　ザ　デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ Ｔ細胞受容体γ代替リーディングフレームタンパク質、（ＴＡＲＰ）およびその用途
WO2004064868A1 (en) * 2003-01-22 2004-08-05 Magnus Essand Tarp promoter and uses thereof
WO2005000889A1 (en) * 2003-06-05 2005-01-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic peptides for the treatment of prostate and breast cancer
EP1849877A1 (en) * 2006-04-24 2007-10-31 Erasmus University Medical Center Rotterdam Replicative history of T-and B-cell subsets
US8188214B2 (en) 2007-02-28 2012-05-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Brachyury polypeptides and methods for use
EP2895191B1 (en) 2012-09-14 2019-06-05 The U.S.A. as represented by the Secretary, Department of Health and Human Services Brachyury protein, adenoviral vectors encoding brachyury protein, and their use
KR101947053B1 (ko) 2013-10-18 2019-02-12 도이체스 크렙스포르슝스첸트룸 전립선 특이적 막 항원（ｐｓｍａ）의 표지된 억제제, 조영제로서의 이의 용도 및 전립선암 치료용 약제
WO2015089469A1 (en) 2013-12-13 2015-06-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Multi-epitope tarp peptide vaccine and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512809A (ja) * 1999-07-13 2004-04-30 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，　リプリゼンテッド　バイ　ザ　セクレタリー　オブ　ザ　デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ Ｔ細胞受容体γ代替リーディングフレームタンパク質、（ＴＡＲＰ）およびその用途
AU2002337657A1 (en) * 2001-07-25 2003-02-17 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
KR20020026530A (ko) 2002-04-10
CN1378594A (zh) 2002-11-06
JP2004512809A (ja) 2004-04-30
WO2001004309A1 (en) 2001-01-18
MXPA02000560A (es) 2003-10-14
US7052703B1 (en) 2006-05-30
RU2002103722A (ru) 2003-08-27
HK1049499A1 (zh) 2003-05-16
NO20020110L (no) 2002-03-12
AU781925B2 (en) 2005-06-23
BR0012446A (pt) 2002-04-02
EP1200585A1 (en) 2002-05-02
CA2379345A1 (en) 2001-01-18
AU6093000A (en) 2001-01-30
NO20020110D0 (no) 2002-01-09
PL354186A1 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB2349510B (en) Keybutton-equipped device
GB2356212B (en) Glass-breaking device
EP1210084A4 (en) PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
IL146151A0 (en) Human-g-protein receptor
IL147507A0 (en) T-cell receptor y and uses thereof
AU6913100A (en) Notch receptor ligands and uses thereof
EP1241586A4 (en) CONTENT DELIVERING DEVICE AND CONTENT USING DEVICE
GB9904906D0 (en) Device
GB9915686D0 (en) Device
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
GB0006110D0 (en) Wear-warning device
GB0013345D0 (en) Modified receptor and assay
GB9904763D0 (en) Device
EP1115266A4 (en) TONWIEDERGEBEGERÄT
GB0030046D0 (en) Releasable retaining device
GB9929581D0 (en) Comjpositions and their use
GB9909903D0 (en) Device
HUP0002798A2 (en) Connecting device
IL149638A0 (en) S-allylmercaptoglutathione and uses thereof
GB9914357D0 (en) Support and integration
GB9916675D0 (en) Enigma-sip and enigma-cell
GB2347614B (en) Milkpan device
GB9916108D0 (en) Boring and overturning device
HU9904583D0 (en) Alpha light-sound device